HNW
BIO icon

High Note Wealth’s Bio-Rad Laboratories Class A BIO Stock Holding History

High Note Wealth’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.23K Buy
+11
New +$3.12K ﹤0.01% 723
2026
Q1 		– Sell
-5
Closed -$1.51K – 945
2025
Q4 		$1.51K Buy
+5
New +$1.56K ﹤0.01% 811
2025
Q3 		– Sell
-16
Closed -$3.86K – 884
2025
Q2 		$3.86K Sell
16
-5
-24% -$1.18K ﹤0.01% 539
2025
Q1 		$5.12K Buy
21
+4
+24% +$1.2K ﹤0.01% 401
2024
Q4 		$5.58K Buy
+17
New +$5.77K ﹤0.01% 401

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

High Note Wealth's BIO Position: Q2 2026 in Review

High Note Wealth opened a new position in Bio-Rad Laboratories Class A (BIO) in Q2 2026: 11 shares worth $3.23K. The stake represents ﹤0.01% of the portfolio and ranks #723 among its holdings. This is a return to the name: High Note Wealth previously reported a position in BIO as recently as Q4 2025.

High Note Wealth first reported a position in BIO in Q4 2024 and has held it in 5 quarters since. The position peaked at $5.58K in Q4 2024. 399 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • High Note Wealth held 11 shares of Bio-Rad Laboratories Class A worth $3.23K as of Q2 2026.
  • Bio-Rad Laboratories Class A was a new High Note Wealth position in Q2 2026.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of High Note Wealth's portfolio in Q2 2026, its #723 holding.
  • High Note Wealth first reported a position in Bio-Rad Laboratories Class A in Q4 2024 and has held it in 5 quarters since.
  • High Note Wealth's Bio-Rad Laboratories Class A position peaked at $5.58K in Q4 2024.
  • 399 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on High Note Wealth's 13F filing for Q2 2026, filed 23 Jul 2026.